Schedule 13D ownership disclosure

Oncology Institute Inc/The

Common Stock, par value $0.0001 per share · CUSIP: 68236X100

Event date: 2025-03-26

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Ravi SarinReported CIK 0001555959

    Shares: 4,109,771.00 · Class: 4.7%

  • OncologyCare Partners, LLCReported CIK 0001752450

    Shares: 4,109,771.00 · Class: 4.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-038121
Form type
SCHEDULE 13D/A
Filer
Oncology Institute, Inc.
CIK
CIK 1799191
Filed
Apr 23, 2025
Reporting period
Mar 26, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub